Media

Trianni, Inc. Announces License Agreement with Nkarta, Inc. for the Trianni Mouse®

SAN FRANCISCO — Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license agreement with Nkarta, Inc. (“NKARTA”) […]

Continue reading

Trianni, Inc. Announces License Agreement with Artizan Biosciences, Inc. for the Trianni Mouse®

San Francisco, CA – Trianni, Inc. (“TRIANNI”) announced on February 25, 2020 that it has entered into a license agreement […]

Continue reading

Mouse Powered Progress: Producing Humanized Monoclonal Antibodies With Transgenic Mice

Antibodies are a critical feature of the human adaptive immune response. New immunotherapies require the production of selective and non-autoimmunogenic […]

Continue reading

TRIANNI is BioWorld’s Partner in Focus

TRIANNI is featured in BioWorld Today as a Partner in Focus. Read the feature here. The feature highlights: • Advantages […]

Continue reading

Biopharma Dealmakers feature The Trianni Mouse Platform

Biopharma Dealmakers from the publishers of Nature, feature TRIANNI, Inc’s Trianni Mouse platform for the discovery of monoclonal antibodies. Read […]

Continue reading

Nature Magazine Profiles TRIANNI

Download Full Feature |   In just a few short years, California-based  TRIANNI Inc. has emerged as one of the […]

Continue reading